FILE-A laboratory technician locations human blood samples on an automatic testing line at a medical facility. (Photograph by David Silverman/Getty Photographs)
Researchers have developed a brand new blood take a look at that may establish most cancers within the physique as a part of a Nationwide Well being Service (NHS) trial within the UK.
What’s the miONCO-Dx take a look at?
Why you must care:
The miONCO-Dx take a look at measures biomarkers, or organic indicators, in a blood pattern and makes use of AI to find cancers.
The expertise was created by the biotechnology firm Xgenera and developed with scientists from the College of Southampton in England.
London media outlet SkyNews reported that 20,000 sufferers have used this take a look at which is 99% correct to find the place cancers are and permitting a prognosis to be carried out when the most cancers is within the early and treatable stage.
How does the blood take a look at work?
Dig deeper:
The take a look at solely requires 10 drops of blood to detect indicators of a dozen cancers nicely earlier than signs develop.
This take a look at can decide widespread cancers, together with lung, gastric, prostate, esophageal, liver, bladder, ovarian, bowel, pancreatic and breast cancers – in addition to bone and mushy tissue sarcoma and a sort of mind tumor.
The Supply: Info for this story was supplied by SkyNews and www.gov.uk, which presents background on the blood take a look at. This story was reported from Washington, D.C.